Sign In
Buy BNGO
$1.30
+0.0400 (+3.17%)
At Close: Jun 03, 2026
Bionano Genomics Data Drives Scientific Discoveries in Solid Tumors and Leukemias, To Be Presented at the 2020 AGBT Conference
01:00pm, Friday, 21'st Feb 2020
Bionano Genomics, Inc. (BNGO), a life sciences instrumentation company that develops and markets Saphyr®, a platform for ultra-sensitive and ultra-specific structural variation detection in genome an
TSLA, INO among premarket gainers
02:16pm, Monday, 10'th Feb 2020
vTv Therapeutics (NASDAQ:VTVT) +80% on positive TTP399 data.Taubman Centers (NYSE:TCO) +52% on being acquired by Simon Property Group.Edgewell Personal Care (NYSE:EPC) +21% after Q4 results.Mereo B
Bionano Genome Imaging Concordant with Traditional Cytogenetics in Landmark Leukemia Study
01:00pm, Monday, 10'th Feb 2020
Bionano Genomics, Inc. (BNGO) announced today that a team led by Dr. Alexander Hoischen from Radboud University Medical Center (RUMC) in the Netherlands reported the results of a successful validation
SAN DIEGO, Jan. 10, 2020 -- Bionano Genomics, Inc. (NASDAQ: BNGO), a life sciences instrumentation company that develops and markets Saphyr®, a platform for ultra-sensitive and.
Bionano Genomics, Inc. (BNGO), a life sciences instrumentation company that develops and markets the Saphyr® System, a genome imaging platform for ultra-sensitive and ultra-specific genome-wide struc
Bionano Genomics Stock on Offer in IPO
07:09pm, Sunday, 15'th Jul 2018
If you've been an Illumina (ILMN) investor for a while, you have to be stoked about how well your investment has performed. This is a company that has an 80% market share selling machines that are t
